JALLAL; BAHIJA

Patent Applications and Registrations

Patent applications and USPTO patent grants for JALLAL; BAHIJA.The latest application filed is for "interferon alpha-induced pharmacodynamic markers and uses thereof".

Company Profile

0.9.31

JALLAL; BAHIJA - GAITHERSBURG MD
Jallal; Bahija - Potomac MD
Jallal; Bahija - Emeryville CA
Jallal; Bahija - Menlo Park CA
Jallal; Bahija - Palo Alto CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Interferon Alpha-induced Pharmacodynamic Markers And Uses Thereof App 20170121771 - YAO; YIHONG ; et al.	2017-05-04
Human Anti Il-6 Antibodies With Extended In Vivo Half-life And Their Use In Treatment Of Oncology, Autoimmune Diseases And Inflammatory Diseases App 20170101468 - Bowen; Michael ; et al.	2017-04-13
Type I Interferon Diagnostic App 20160024205 - Higgs; Brandon ; et al.	2016-01-28
Anti-ICOS antibodies and their use in treatment of oncology, transplantation and autoimmune disease Grant 9,193,789 - Coyle , et al. November 24, 2	2015-11-24
Type 1 Interferon Diagnostic App 20150191788 - HIGGS; BRANDON ; et al.	2015-07-09
Interferon Alpha-induced Pharmacodynamic Markers And Uses Thereof App 20150147336 - YAO; Yihong ; et al.	2015-05-28
Interferon Alpha-induced Pharmacodynamic Markers App 20150132313 - YAO; Yihong ; et al.	2015-05-14
Interferon Alpha-induced Pharmacodynamic Markers And Uses Thereof App 20150044222 - YAO; Yihong ; et al.	2015-02-12
Human Anti Il-6 Antibodies With Extended In Vivo Half-life And Their Use In Treatment Of Oncology, Autoimmune Diseases And Inflammatory Diseases App 20140302058 - Bowen; Michael ; et al.	2014-10-09
Methods For Diagnosis And Treatment Of Proliferative Disorders Mediated By Cd40 Signaling App 20130230528 - Aukerman; Sharon Lea ; et al.	2013-09-05
Anti-icos Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease App 20130142783 - COYLE; Anthony ; et al.	2013-06-06
Methods of monitoring the efficacy of anti-CD40 antibodies in treating a subject for a CD40-expressing cancer Grant 8,337,851 - Aukerman , et al. December 25, 2	2012-12-25
Methods of monitoring the efficacy of anti-CD40 antibodies in treating a subject having an inflammatory or autoimmune disease Grant 8,333,970 - Aukerman , et al. December 18, 2	2012-12-18
Type 1 Inteferon Diagnostic App 20120251546 - Higgs; Brandon ; et al.	2012-10-04
Phosphospecific Pak Antibodies And Diagnostic Kits App 20120045775 - SMEAL; Tod R. ; et al.	2012-02-23
Human Anti-IL-6 Antibodies With Extended In Vivo Half-Life And Their Use In Treatment Of Oncology, Autoimmune Diseases And Inflammatory Diseases App 20120034212 - Bowen; Michael ; et al.	2012-02-09
Interferon Alpha-induced Pharmacodynamic Markers App 20110287022 - Yao; Yihong ; et al.	2011-11-24
Disease Markers And Uses Thereof App 20110262928 - Yao; Yihong ; et al.	2011-10-27
Anti-icos Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease App 20110243929 - COYLE; Anthony ; et al.	2011-10-06
GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF App 20110159532 - Smeal; Tod R. ; et al.	2011-06-30
GEF-H1b: biomarkers, complexes, assays and therapeutic uses thereof Grant 7,871,786 - Smeal , et al. January 18, 2	2011-01-18
Interferon Alpha-induced Pharmacodynamic Markers App 20100261172 - Yao; Yihong ; et al.	2010-10-14
Interferon Alpha-induced Pharmacodynamic Markers App 20100143372 - Yao; Yihong ; et al.	2010-06-10
Phosphospecific PAK antibodies and diagnostic kits App 20090215063 - SMEAL; TOD R. ; et al.	2009-08-27
GEF-H1b: biomarkers, complexes, assays and therapeutic uses thereof App 20090130695 - Smeal; Tod R. ; et al.	2009-05-21
Methods For Diagnosis And Treatment Of Proliferative Disorders Mediated By Cd40 Signaling App 20090041773 - Aukerman; Sharon Lea ; et al.	2009-02-12
Anti-icos Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease App 20080279851 - COYLE; Anthony ; et al.	2008-11-13
Methods for Diagnosis and Treatment of Diseases Having an Autoimmune and/or Inflammatory Component App 20080274118 - Aukerman; Sharon Lea ; et al.	2008-11-06
GEF-H1b: biomarkers, complexes assays and therapeutic uses thereof Grant 7,439,329 - Smeal , et al. October 21, 2	2008-10-21
Diagnosis and treatment of PTP related disorders App 20080009610 - Plowman; Gregory D. ; et al.	2008-01-10
Diagnosis and treatment of PTP related disorders Grant 7,115,710 - Plowman , et al. October 3, 2	2006-10-03
Diagnosis and treatment of PTP related disorders App 20060019305 - Plowman; Gregory D. ; et al.	2006-01-26
Phosphospecific PAK antibodies and diagnostic kits App 20050054017 - Smeal, Tod R. ; et al.	2005-03-10
Diagnosis and treatment of PTP04 related disorders Grant 6,844,177 - Jallal , et al. January 18, 2	2005-01-18
Phosphate mimics and methods of treatment using phosphatease inhibitors App 20040138255 - Huang, Ping ; et al.	2004-07-15
GEF-H1b: biomarkers, complexes assays and therapeutic uses thereof App 20040091907 - Smeal, Tod R. ; et al.	2004-05-13
Phosphate mimics and methods of treatment using phosphatase inhibitors Grant 6,596,772 - Huang , et al. July 22, 2	2003-07-22
Diagnosis and treatment of PTP04 related disorders App 20020119501 - Jallal, Bahija ; et al.	2002-08-29

Company Registrations

SEC

0001730038

Jallal Bahija

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.